As we observe the trends in Animal healthcare market globally, we find that South America is one of the regions which has a lot to offer and is an untapped market compared to the likes of North America and Europe.This article examines the regional animal health care companies in South America which are on the rise and are also potential acquisition targets for animal healthcare market players who want to enter this goldmine, which is South America.Part 1 of the article provides you an insight on the companies Ouro Fino Saude Animal and Biogenesis Bago, considered one of the top animal health organizations in the South American region. The article focused on what Ouro Fino Saude Animal and Biogenesis Bago are doing it right which made them the company to watch out for globally.Part 2 provides you with an insight on other animal healthcare companies to watch out for in the South American region.Third on the list (Following Ouro Fino Saude Animal and Biogenesis Bago) is the Brazilian outlet Vencofarma. It was founded in the year 1986 and is based out of the city of Londrina, Parana State, Brazil. They specialize in manufacturing anti venom vaccines. This company was started as result of Syntex leaving the Brazilian market which created a void in anti-venom serum supplies. This company manufactures vaccines, medicines and provides diagnostic services for both pet and farm animals. The company has a strong presence in the whole of the South American region with operations almost everywhere in South America. They also have operations in some parts of Asia, Middle East and Africa. They are financially strong. They have generated a revenue of $18.5 million for the year 2013. The company expects to generate $22.5 million for the 2014 financial year which shows an increase in revenue by a staggering 19%. They have started to expand their presence to regions such as Russia and USA. They will look out for companies to collaborate so as to have a smooth entry as well as ready access to the markets. So this is an opportunity for the organizations in the markets of USA and Russia to collaborate with Vencofarma which can help them in their entry into the untapped treasure of the animal health market in South America. This surely is a company to watch out for.Next on the list is the Argentinian market player Vetanco. Founded in 1987, Vetanco is headquartered in Buenos Aires operating in more than 40 nations around the world. This company mainly manufacturers’ antibiotics, anticoccidials, parasiticides, probiotics and feed additives for animals. It has a strong presence in the whole of South America and in the developing nations of Asia and Africa. What they are doing it right is that they are constantly innovating and producing great products for the treatment of animal diseases. They have recently launched a new ambifluid benzuron bovine vaccine which stops the growth of the flies in cattle farms. Their activity in the market is considerably good. They have recently started operations in Mexico thereby expanding their Latin American market. They have also successfully registered their products in Turkey, Russia and Azerbaijan. This can help them extend their market presence in these regions and neighboring countries gradually. Their products are being sold in Indonesia, Zambia, Slovenia, Egypt and other countries around the globe. At this rate, Vetanco has all what it takes to become a major market player globally in the future. They are looking at opportunities to collaborate with other organizations to extend their global spread. This can be a chance for other players to collaborate and can act as an entry into the South American market.Next on the list is União Quimica Animal Health. Founded in 2000, it is one of the youngest representatives of the Brazilian veterinary market. It is based from the city of Sao Paulo. They specialise in manufacturing pharmaceutical products for both companion and farm animals. Products mainly include antibiotics, anti parasiticides, sedatives, analgesics, Endoparaciticide, and ectoparasiticides and a few others. With a very strong presence in South America as one of the leading pharmaceutical companies in Brazil, it is constantly looking for opportunities to collaborate with other organizations to expand their presence beyond South America. This company is a probable acquisition target for other companies who plan to penetrate the Brazil animal health market.The trend to be observed in the way these companies operate is that they have good presence in the African market and in some regions of the Asian market which are comparatively less penetrated compared to the likes of North America and Europe.In conclusion it can be said that there are ample opportunities for market players planning to enter the animal health market in South American market and there are a lot of upcoming companies to collaborate or acquire them, thereby providing you a smooth transition while entering the market.
Over the years, the animal health care industry has been witnessing robust growth. The market has been on the rise over the past few years, thanks to the growing demand to cater to the needs of animal healthcare (both companion and farm animals) that was ignored previously when compared with the likes of human health. This ignorance resulted in a situation, where diseases affecting the animals grew exponentially and proper healthcare measures for animals were limited. This has resulted in a movement where organizations all around the world witnessed the immense need to cater to the needs of animal health, which became a huge prospect financially.Currently the animal health market in the developed nations is on the verge of stagnation due to a lot of mergers and acquisition activity and complete penetration of the market by the major players in these regions. This has led to a situation where the animal healthcare companies have started looking to high potential markets. This apart, the unmet demand and favorable government policies has made companies to look into promising markets such as South America, a market with huge potential and unlimited opportunities.In this article we provide you with information regarding the leading animal healthcare companies in South America that are performing well and are potential acquisition targets for leading healthcare companies in the world who are planning to enter the South American animal health care market.Think of this article as a scouting report for some of the animal healthcare companies in South America.First on the list of companies to watch out for is the Brazilian company ‘Ouro Fino Saude Animal’. It is considered to be one of the top animal healthcare companies in Brazil. They manufacture healthcare products for animals which include antimicrobials, anti-parasites, vaccines, vitamin supplements, antibiotics, probiotics, etc. They have a major presence in the South American and Latin American market with operations in Africa and some parts of Asia. Recently they have been in the news for they have started their first IPO in a bid to raise capital for business expansion. This was the first IPO in Brazil in 2014. This IPO was a success despite the economic and political uncertainties in Brazil. They were able to generate nearly $170 million through the IPO offering which they will be using it for expanding their product inventory. They are a stable company. They recorded a 19.92% increase in the revenue for 2013 and clocked $152 million in turnover. Considering their presence in the African market, this company is a very good target for acquisition.Next on the list is the Argentinian animal health company ‘Biogenesis Bago’. Founded in 2006 and based out of Garin, Argentina, it is one of the leading South American animal healthcare companies with presence in the regions of Brazil, Central America, Bolivia, Uruguay and others. They manufacture biological and pharmaceutical products for farm animals. They are considered experts in the field of Food and Mouth Vaccines (FMD Vaccines). At the time of 2006, Biogenesis Bago was the only Latin American market player to be rewarded with an approval by the North American FMD Vaccines to cater the needs of the North American region (USA, Canada and Mexico). They have been looking out for opportunities to expand their market globally. They have offered their services in China by providing FMD vaccines. They have set up operations in Yangling in collaboration with HILE biotechnology, a company that produces vaccines for swine and poultry. This is the first Non- Chinese Company to produce vaccines in China and the second Argentinian company to have operations in China. This company is a very hot prospect in the animal health market. It can either make its way through the animal health care market on a global arena or it can collaborate with other companies outside the South American region to expand their business and an opportunity for others who want to enter the South American animal health market. This company is one to watch out for as it is set to reach great heights in the future.(This article is Part 1 of the two series article based on “Animal Health companies to watch out for- South America).